Respiratory disease is the diseases and disorders of the airways and the lungs that affect human respiration. Respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), sleep apnea and others may be caused by infection, by smoking tobacco, or by breathing in second hand tobacco smoke, radon, asbestos, or other forms of air pollution. Respiratory care device are used for the diagnosis, treatment and monitoring of Respiratory diseases. These devices help patients in need of support for breathing, removal of carbon dioxide, and therapy to reduce disuse atrophy of abdominal wall muscles. Technological advancements in respiratory care devices and funding for the development of innovative respiratory technologies further boost the growth of market.
Glucose Monitoring consists of products that are essential for measuring glucose levels in diabetes patients. With the projected rise in the aged population and awareness about diabetes conditions, the market is focused on growing with newer technology and improved products. According to IQ4I analysis, the glucose monitoring global market is expected to grow at a double digit CAGR from 2022 to 2029 reach $33,886.4 million by 2029.
Neuromodulation is the alteration of nerve activity through the delivery of an electric and magnetic stimulus. Applications for neuromodulation include therapies for a wide range of disorders, as well as a tool for medical and neuroscientific research. It is used as a treatment for unmanageable chronic pain, movement disorders, neurological diseases, gastroenterology, respiratory related diseases and others. The treatment delivered by neuromodulation devices brings about life-changing transformation in patients who fail to get better by traditional approaches. This therapy is based on the natural process of stimulation of nerve cell activity and release of neurotransmitters that regulate nerve activity.
Heart failure is a condition in which the heart is unable to pump enough blood to meet the body's needs; it can be either an acute or chronic condition. Some of the common causes of heart failure include coronary artery disease, heart attack, high blood pressure, atrial fibrillation, valvular heart disease, and cardiomyopathy. Factors such as increasing incidence of heart failure diseases, technological advancement in heart failure devices, rising geriatric population, and favorable reimbursement are the drivers, vast pipeline products, increase in funding and approvals are the opportunities.
Factors such as the growing patient population with chronic conditions increasing the demand for embolization procedures, and technology advancements are driving the market growth, whereas, acquisitions and collaborations and emerging markets are providing growth opportunities for the embolotherapy market.
The factors such as increasing prevalence of cancer cases, growing adoption of minimally invasive procedures, increasing geriatric population, technological advancements in the field of interventional oncology, and expansion in the emerging markets are driving the market.
Surgical sealants, adhesives, and hemostats (SAH) are used to close surgical incisions, post-surgical application, block the passage of fluids through the surface or openings of the wounds, and also to avoid microbial adhesions and infections. Sealants and adhesives are considered together as they both adhere to and seal the surgical incisions, while, hemostats are used to achieve hemostasis when the conventional method is ineffective and impractical.
Increasing popularity of prefilled syringes among patients and healthcare professionals, increasing predisposition of pharmaceutical companies towards prefilled syringes, preferential adoption of prefilled syringes for the delivery of various highly viscous and sensitive biopharmaceuticals, emergence of technologically advanced prefillable syringe products, increasing number of prefilled syringes being approved by regulatory authorities across the globe are some of the factors propelling the prefilled syringe market growth.
Factors like necessity to curb patient safety threatening and economically straining Healthcare Associated Infections (HAIs), the requisite to sterilize the reusable high risk or critical surgical instruments used in the persistently escalating surgical procedures across the globe, the regulatory mandate of terminal sterilization or aseptic processing of healthcare products before commercialization, increasing trend of outsourcing of sterilization services by the healthcare industry, constant progressive refinements of various sterilization technologies, the gradual transition of medical devices market from reprocessed to the value enhanced single use devices and the necessity to terminally sterilize the huge volume of disposable devices, steadily increasing and advancing healthcare facilities, healthcare industry and research settings across the globe with increased utilization of various sterilization products and the persistently elevating fragile geriatric population burdened with several co-morbidities with increased medical needs and increased vulnerability to HAIs are propelling the sterilization market growth.
The factors like the increasing trend of outsourcing among the medical device OEMs to enhance the speed to market of their proprietary products economically, the necessity for OEMs to perpetuate their market share and achieve operational efficiency and competitive edge over their peers by gaining timely, economical access to the advanced, scale appropriate and multiple product manufacturing capabilities of CMOs, the need to meet the huge volume medical device demand associated with persistently escalating prevalence of chronic and infectious diseases and varying medical needs of steadily escalating geriatric population, the gradual transition of medical device market to the value enhanced and cost-efficient disposable devices, increase in surgical procedural volume, hospitalizations and developing healthcare facilities across the globe, the requirement of medical device companies to stay abreast in the highly competitive medical device market with technologically advanced medical devices, and the trend of consolidation in the market are propelling the market growth.
An increase in the prevalence of diabetes, advantages of insulin pumps in the home care setting, and increasing distribution agreements, partnerships and collaboration activities, are the factors driving the market growth.
Increasing demand for minimally invasive surgical procedure leading fast recovery and reduced hospital stays, technological innovations offering a wider scope of applications for endoscopy, the rise in obese population preferring bariatric surgery for weight reduction are the factors driving the market growth.